190 related articles for article (PubMed ID: 37994754)
21. Integration of Genomic Profiling and Organoid Development in Precision Oncology.
Yoon H; Lee S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008642
[TBL] [Abstract][Full Text] [Related]
22. A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine.
Turanli B; Karagoz K; Gulfidan G; Sinha R; Mardinoglu A; Arga KY
Curr Pharm Des; 2018; 24(32):3778-3790. PubMed ID: 30398107
[TBL] [Abstract][Full Text] [Related]
23. G-DOC: a systems medicine platform for personalized oncology.
Madhavan S; Gusev Y; Harris M; Tanenbaum DM; Gauba R; Bhuvaneshwar K; Shinohara A; Rosso K; Carabet LA; Song L; Riggins RB; Dakshanamurthy S; Wang Y; Byers SW; Clarke R; Weiner LM
Neoplasia; 2011 Sep; 13(9):771-83. PubMed ID: 21969811
[TBL] [Abstract][Full Text] [Related]
24. Using knowledge-driven genomic interactions for multi-omics data analysis: metadimensional models for predicting clinical outcomes in ovarian carcinoma.
Kim D; Li R; Lucas A; Verma SS; Dudek SM; Ritchie MD
J Am Med Inform Assoc; 2017 May; 24(3):577-587. PubMed ID: 28040685
[TBL] [Abstract][Full Text] [Related]
25. Bayesian tensor factorization-drive breast cancer subtyping by integrating multi-omics data.
Liu Q; Cheng B; Jin Y; Hu P
J Biomed Inform; 2022 Jan; 125():103958. PubMed ID: 34839017
[TBL] [Abstract][Full Text] [Related]
26. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
27. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
Castrillo JI; Lista S; Hampel H; Ritchie CW
Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
[TBL] [Abstract][Full Text] [Related]
28. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
29. Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence.
Hampel H; Nisticò R; Seyfried NT; Levey AI; Modeste E; Lemercier P; Baldacci F; Toschi N; Garaci F; Perry G; Emanuele E; Valenzuela PL; Lucia A; Urbani A; Sancesario GM; Mapstone M; Corbo M; Vergallo A; Lista S;
Ageing Res Rev; 2021 Aug; 69():101346. PubMed ID: 33915266
[TBL] [Abstract][Full Text] [Related]
30. BRCA-Pathway: a structural integration and visualization system of TCGA breast cancer data on KEGG pathways.
Kim I; Choi S; Kim S
BMC Bioinformatics; 2018 Feb; 19(Suppl 1):42. PubMed ID: 29504910
[TBL] [Abstract][Full Text] [Related]
31. Omics for the future in asthma.
Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
[TBL] [Abstract][Full Text] [Related]
32. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
33. Survey and comparative assessments of computational multi-omics integrative methods with multiple regulatory networks identifying distinct tumor compositions across pan-cancer data sets.
Wei Z; Zhang Y; Weng W; Chen J; Cai H
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32533167
[TBL] [Abstract][Full Text] [Related]
34. Omics sciences and precision medicine in kidney cancer.
Dhuli K; Micheletti C; Medori MC; Maltese PE; Tanzi B; Tezzele S; Mareso C; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):46-54. PubMed ID: 37994748
[TBL] [Abstract][Full Text] [Related]
35. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis.
Ahmed Z
Prog Mol Biol Transl Sci; 2022; 190(1):101-125. PubMed ID: 36007996
[TBL] [Abstract][Full Text] [Related]
36. Omics sciences and precision medicine in lung cancer.
Micheletti C; Dhuli K; Donato K; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):37-45. PubMed ID: 37994747
[TBL] [Abstract][Full Text] [Related]
37. Changing Landscape of Clinical-Genomic Oncology Practice.
Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
[TBL] [Abstract][Full Text] [Related]
38. Integration of Online Omics-Data Resources for Cancer Research.
Das T; Andrieux G; Ahmed M; Chakraborty S
Front Genet; 2020; 11():578345. PubMed ID: 33193699
[TBL] [Abstract][Full Text] [Related]
39. Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine.
Cai D; Liu T; Fang J; Liu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9151-9165. PubMed ID: 37178426
[TBL] [Abstract][Full Text] [Related]
40. A critical review of datasets and computational suites for improving cancer theranostics and biomarker discovery.
Ashok G; Ramaiah S
Med Oncol; 2022 Sep; 39(12):206. PubMed ID: 36175717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]